VIEWPOINTS PharmaShots Interview: BMS’ Dr. Ian Waxman Shares Insights on the Opdivo (nivolumab) + Yervoy (ipilimumab) for dMMR or MSI-H mCRCBySenior EditorSeptember 28, 20210Comments
VIEWPOINTS PharmaShots Interview: Zealand Pharma’s Dr. David Kendall Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with DiabetesBySenior EditorSeptember 27, 20210Comments
VIEWPOINTS PharmaShots Interview: Dr. Philip Mease Shares Insights on the Clinical data of Tremfya (guselkumab) Presented in The Lancet RheumatologyBySenior EditorSeptember 22, 20210Comments
VIEWPOINTS PharmaShots Interview: Durect’s James E. Brown Shares Insight on the Data of DUR-928 Presented at EASL 2021BySenior EditorSeptember 20, 20210Comments
EXCLUSIVE Exclusive Interview with PharmaShots: Ron Elwell of IPM.ai Shares Insight on the Simplification of Patient Recruitment by Applying AI and ML to Real-World DataBySenior EditorSeptember 20, 20210Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in August 2021BySenior EditorSeptember 16, 20210Comments
VIEWPOINTS PharmaShots Interview: TFF’s Dr. Dale Christensen Shares Insight on the Thin Film Freezing TechnologyBySenior EditorSeptember 15, 20210Comments
VIEWPOINTS PharmaShots Interview: Recce Pharmaceuticals’ James Graham Shares Insight on the P-I/II Clinical Trial of RECCE 327 (R327) for Infected Burn WoundsBySenior EditorSeptember 14, 20210Comments
